Investment Advisory Board

The Blavatnik Investment Advisory Board is made up of leading executives and investors from successful life sciences companies across the country. The board was formed with the support of the Provost and all members have deep technical expertise in the life sciences, extensive business backgrounds and strong connections to Yale.

Fred Cohen
Fred Cohen, D.Phil, M.D., Board Chairman
TPG Biotech

Stephen Knight, M.D., M.B.A.
President & Managing Partner
Liam Ratcliffe, M.D., Ph.D., M.B.A.
Managing Director
Jason Rhodes, M.B.A.
Tim Shannon, M.D.
General Partner
David Singer, M.B.A.
Managing Partner
Venture Partner
Senior Managing Director
Executive Vice President

Faculty Representative

Amy Arnsten, Ph.D.
Prof, Neuroscience & Psychology
Arnsten Lab at Yale